+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Peptide Hormone"

Gout Therapeutics Global Market Report 2024 - Product Thumbnail Image

Gout Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Dementia with Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia with Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Synthetic Hormones Global Market Report 2024 - Product Thumbnail Image

Synthetic Hormones Global Market Report 2024

  • Report
  • April 2024
  • 175 Pages
From
From
Melanocyte Stimulating Hormone Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanocyte Stimulating Hormone Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 80 Pages
  • Global
From
Global Human Insulin Market 2018-2024 - Product Thumbnail Image

Global Human Insulin Market 2018-2024

  • Report
  • February 2018
  • 77 Pages
  • Global
From
  • 20 Results (Page 1 of 1)
Loading Indicator

The Peptide Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Peptide hormones are a type of hormone that are composed of amino acids and are secreted by the endocrine glands. They are involved in a variety of physiological processes, including growth, metabolism, reproduction, and stress response. Peptide hormones are used to treat a variety of endocrine and metabolic disorders, such as diabetes, obesity, and hypothyroidism. They are also used to treat certain types of cancer, such as prostate cancer. Peptide hormones are typically administered via injection or inhalation. They are generally well-tolerated and have few side effects. However, they can be expensive and may require frequent dosing. Some companies in the Peptide Hormone market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and Pfizer. Show Less Read more